Predictors of survival in patients with myasthenia gravis and thymoma

被引:2
|
作者
López-Cano, M [1 ]
Bosch, JMP [1 ]
Basany, EE [1 ]
García, JLS [1 ]
Carrasco, MA [1 ]
机构
[1] Hosp Gen Valle Hebron, E-08035 Barcelona, Spain
来源
MEDICINA CLINICA | 2003年 / 120卷 / 11期
关键词
Myasthenia Gravis; thymoma; survival;
D O I
10.1157/13045303
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND AND OBJECTIVE: Myasthenia Gravis (MG) and Thymoma have different clinical evolutions and survival. There are few studies grying to describe the prognosis factors in patients with both thymoma and MG. We have evaluated all patients with thymoma and associated MG who were treated in our unit in order to identify possible predictors of survival. PATIENTS AND METHOD: There were 108 patients with thymoma and associated MG treated at our center from 1967 to 2000. All data were analyzed by multivariate Cox regression analysis, which allowed quantification of the independent predictive value of prognostic indicators. RESULTS: Median follow-up was 10 years. Mortality was 35.2% (38 patients). In 14 (36.8%) cases, death was related to MG, and 6 (15.8%) patients died from a cause directly related to thymoma. Cox regression analysis found a predictive value for both an age older than 55 years and the need for tracheostomy during the postoperative period. CONCLUSIONS: In our series of patients with thymoma and associated MG, age older than 55 years and the need for postoperative tracheostomy were independent predictors of poorer overall survival.
引用
收藏
页码:401 / 404
页数:4
相关论文
共 50 条
  • [1] Molecular profiling of thymoma with myasthenia gravis: Risk factors of developing myasthenia gravis in thymoma patients
    Lee, Ming-Ching
    Hsiao, Tzu-Hung
    Chuang, Han-Ni
    Lee, Li-Wen
    Chi, Pei-Ling
    Tsai, Hui-Mei
    Mao, Chien-Lin
    Hsu, Chung-Ping
    LUNG CANCER, 2020, 139 : 157 - 164
  • [2] IMMUNODEFICIENCY IN PATIENTS WITH MYASTHENIA GRAVIS AND A THYMOMA
    Tamayev, R.
    Nassau, S.
    Rubinstein, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S103 - S103
  • [3] Thymoma recurrences in myasthenia gravis patients
    Evoli, A
    Batocchi, AP
    Lino, MM
    Tonali, P
    Lauriola, L
    Doglietto, GB
    MYASTHENIA GRAVIS AND RELATED DISEASES: DISORDERS OF THE NEUROMUSCULAR JUNCTION, 1998, 841 : 781 - 784
  • [4] Myasthenia gravis and thymoma
    De Assis, JL
    Zambon, AA
    Souza, PS
    Marchiori, PE
    ARQUIVOS DE NEURO-PSIQUIATRIA, 1999, 57 (01) : 6 - 13
  • [5] Myasthenia gravis with thymoma
    Oosterhuis, HJGH
    Kuks, JBM
    EPITHELIAL TUMORS OF THE THYMUS: PATHOLOGY, BIOLOGY, TREATMENT, 1997, : 271 - 280
  • [6] Myasthenia gravis with thymoma
    Jones, W. A.
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1916, 67 : 1354 - 1357
  • [7] Thymoma in myasthenia gravis
    Gillespie, B
    ARCHIVES OF PATHOLOGY, 1941, 32 (04): : 659 - 663
  • [8] THE THYMOMA AND MYASTHENIA GRAVIS
    MENDELOW, H
    GENKINS, G
    AMERICAN JOURNAL OF PATHOLOGY, 1958, 34 (03): : 563 - 564
  • [9] A study of myasthenia gravis in patients with and without thymoma
    Roy, A
    Kalita, J
    Misra, UK
    Kar, D
    Agarwal, A
    Misra, SK
    NEUROLOGY INDIA, 2000, 48 (04) : 343 - 346
  • [10] Myasthenia gravis in patients with thymoma affects survival rate following extended thymectomy
    Zhang, Zhefeng
    Cui, Youbin
    Jia, Rui
    Xue, Lei
    Liang, Huagang
    ONCOLOGY LETTERS, 2016, 11 (06) : 4177 - 4182